Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine Therapy in Traumatic Brain Injury
NCT05569993Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial in traumatic brain injury (TBI) comparing Glutamine Group with Placebo Group (2 arms). Primary endpoint: The duration of ICU stay at 30 days. Status: unknown.
02
Drugs
glutamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05569993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05569993.